Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (43)
2024
-
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions
International Journal of Antimicrobial Agents, Vol. 63, Núm. 5
-
Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803
-
Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 279-296
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
-
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study
Eurosurveillance, Vol. 29, Núm. 15
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
-
Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis
European Journal of Haematology
-
Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group
Clinical Microbiology and Infection
-
Use of Galleria mellonella as an Animal Model for Studying the Antimicrobial Activity of Bacteriophages with Potential Use in Phage Therapy
Methods in Molecular Biology (Humana Press Inc.), pp. 171-180
2023
-
A highly-safe live auxotrophic vaccine protecting against disease caused by non-typhoidal Salmonella Typhimurium in mice
Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 2, pp. 324-336
-
A new and efficient enrichment method for metagenomic sequencing of Monkeypox virus
BMC Genomics, Vol. 24, Núm. 1
-
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain
International Journal of Antimicrobial Agents, Vol. 61, Núm. 4
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Automatic antibiotic resistance prediction in Klebsiella pneumoniae based on MALDI-TOF mass spectra
Engineering Applications of Artificial Intelligence, Vol. 118
-
Bacterial Pathogenesis and Antimicrobial Strategy
Antibiotics
-
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases
Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923
-
Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection
Frontiers in Medicine, Vol. 10
-
Comparison of the in vivo efficacy of ceftaroline fosamil, vancomycin and daptomycin in a murine model of methicillin-resistant Staphylococcus aureus bacteraemia
International Journal of Antimicrobial Agents, Vol. 62, Núm. 1
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)
Frontiers in Microbiology